Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study

INTRODUCTION: Triptorelin is available as 1- and 3-month prolonged-release (PR) formulations; at the time of the study, only the former was approved for central precocious puberty (CPP) in China. This study assessed the efficacy and safety of the triptorelin 3-month PR formulation in Chinese childre...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xiaoping, Zhang, Cai, Yang, Yu, Xu, Xu, Cheng, Xinran, Wei, Haiyan, Wang, Lanying, Huang, Frank, Shi, Xiaofeng, Cabri, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499740/
https://www.ncbi.nlm.nih.gov/pubmed/37584898
http://dx.doi.org/10.1007/s12325-023-02617-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499740/
https://www.ncbi.nlm.nih.gov/pubmed/37584898
http://dx.doi.org/10.1007/s12325-023-02617-8

Ejemplares similares